IGF1 and type 2 diabetes mellitus: For example, inclusion of additional biomarkers from the IGF/IGFBP system pathway such as IGF-1, IGF-2, IGFBP-1, and IGFBP-3 would have been helpful to better estimate the contribution of this system to the T2D and CVD risk.